MEP38708A - Use of hcg and lh in controlled ovarian hyperstimulation - Google Patents

Use of hcg and lh in controlled ovarian hyperstimulation

Info

Publication number
MEP38708A
MEP38708A MEP-387/08A MEP38708A MEP38708A ME P38708 A MEP38708 A ME P38708A ME P38708 A MEP38708 A ME P38708A ME P38708 A MEP38708 A ME P38708A
Authority
ME
Montenegro
Prior art keywords
hcg
ovarian hyperstimulation
controlled ovarian
rates
decreased
Prior art date
Application number
MEP-387/08A
Other languages
Bosnian (bs)
English (en)
Croatian (hr)
Inventor
Yves Menezo
Original Assignee
Merck Serono Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8182262&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MEP38708(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Merck Serono Sa filed Critical Merck Serono Sa
Publication of MEP38708A publication Critical patent/MEP38708A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/11—Gonadotropin; related peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/13—Luteinizing hormone-releasing hormone; related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Veterinary Medicine (AREA)
  • Reproductive Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicinal Preparation (AREA)
MEP-387/08A 2001-09-12 2002-09-12 Use of hcg and lh in controlled ovarian hyperstimulation MEP38708A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01307758 2001-09-12
PCT/GB2002/004167 WO2003022303A2 (fr) 2001-09-12 2002-09-12 Utilisation de hcg et de lh in dans l'hyperstimulation ovarienne controlee

Publications (1)

Publication Number Publication Date
MEP38708A true MEP38708A (en) 2011-02-10

Family

ID=8182262

Family Applications (1)

Application Number Title Priority Date Filing Date
MEP-387/08A MEP38708A (en) 2001-09-12 2002-09-12 Use of hcg and lh in controlled ovarian hyperstimulation

Country Status (26)

Country Link
US (1) US7402558B2 (fr)
EP (1) EP1425033B1 (fr)
JP (1) JP2005501919A (fr)
KR (1) KR20040032952A (fr)
CN (1) CN100376289C (fr)
AR (1) AR036593A1 (fr)
AT (1) ATE489964T1 (fr)
BR (1) BR0212447A (fr)
CA (1) CA2457851A1 (fr)
CY (1) CY1110991T1 (fr)
DE (1) DE60238490D1 (fr)
DK (1) DK1425033T3 (fr)
EA (1) EA009279B1 (fr)
ES (1) ES2356895T3 (fr)
HR (1) HRP20040086A2 (fr)
IL (1) IL160782A0 (fr)
ME (1) MEP38708A (fr)
MX (1) MXPA04002257A (fr)
NO (1) NO327153B1 (fr)
PL (1) PL369021A1 (fr)
PT (1) PT1425033E (fr)
SI (1) SI1425033T1 (fr)
UA (1) UA82052C2 (fr)
WO (1) WO2003022303A2 (fr)
YU (1) YU21104A (fr)
ZA (1) ZA200400781B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040248784A1 (en) * 2003-06-03 2004-12-09 Marco Filicori Unitary combinations of FSH and hCG
GB0723882D0 (en) * 2007-12-07 2008-01-23 Univ Leicester Methods for the detection of a threatened miscarriage
BR112014001274A2 (pt) 2011-07-18 2017-04-18 Arts Biologics As composto de hormônio luteinizante, e, composição farmacêutica
EP2968391A1 (fr) 2013-03-13 2016-01-20 Moderna Therapeutics, Inc. Molécules polynucléotidiques à longue durée de vie
EP3037101B1 (fr) * 2014-12-22 2019-03-06 Ferring B.V. Thérapie par antagoniste du récepteur de l'oxytocine dans la phase lutéinique pour l'implantation et la grossesse chez les femmes subissant des technologies de reproduction assistée
PL3261661T3 (pl) * 2015-02-26 2024-03-25 Ferring B.V. Menotropina do leczenia niepłodności
WO2017192847A1 (fr) * 2016-05-04 2017-11-09 University Of Cincinnati Thérapies de la fertilité femelle
TWI846743B (zh) 2018-10-17 2024-07-01 荷蘭商菲林公司 用於控制性卵巢刺激之組成物及方法
CN110041436A (zh) * 2019-04-28 2019-07-23 广州威生医药科技有限公司 长效重组fsh融合蛋白在母猪批次化生产中的应用
TW202210096A (zh) * 2020-05-29 2022-03-16 荷蘭商菲林公司 治療不育症之方法
CN116148483A (zh) * 2023-04-20 2023-05-23 北京大学第三医院（北京大学第三临床医学院） 用于确定多囊卵巢综合征fsh起始剂量的标记物及其应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4589402A (en) 1984-07-26 1986-05-20 Serono Laboratories, Inc. Method of in vitro fertilization
US5705478A (en) * 1989-02-21 1998-01-06 Washington University Covalently linked β subunits of the glycoprotein hormones as antagonists
FR2744367B1 (fr) * 1996-02-02 1999-07-09 Emperaire Jean Claude Medicaments pour le declenchement de l'ovulation
ATE302018T1 (de) * 1997-06-20 2005-09-15 Akzo Nobel Nv Gonadotropin releasing hormon antagonist
ZA987497B (en) * 1997-09-08 1999-02-23 Akzo Nobel Nv Expression of gonadotropins in dictyostelium
US6090848A (en) * 1997-12-01 2000-07-18 Sigma-Tau Healthscience S.P.A. Compositions and methods for increasing the concentration and/or motility of spermatozoa in humans
CN1353617A (zh) 1999-02-24 2002-06-12 诺沃挪第克公司 不孕症的治疗
PT1176976E (pt) * 1999-05-07 2006-11-30 Applied Research Systems Utilização de lh administrada na fase folicular média e tardia para o tratamento de mulheres anovulatórias.
CA2397680A1 (fr) * 2000-01-27 2001-08-02 Applied Research Systems Ars Holding N.V. Utilisation de fsh pour traiter l'infertilite
US6953774B2 (en) * 2000-08-11 2005-10-11 Applied Research Systems Ars Holding N.V. Methods of inducing ovulation

Also Published As

Publication number Publication date
CN100376289C (zh) 2008-03-26
KR20040032952A (ko) 2004-04-17
JP2005501919A (ja) 2005-01-20
PL369021A1 (en) 2005-04-18
NO20040962L (no) 2004-03-05
ATE489964T1 (de) 2010-12-15
BR0212447A (pt) 2004-08-17
YU21104A (sh) 2006-08-17
IL160782A0 (en) 2004-08-31
PT1425033E (pt) 2010-12-29
CY1110991T1 (el) 2015-06-11
EP1425033A2 (fr) 2004-06-09
US20050020489A1 (en) 2005-01-27
ZA200400781B (en) 2005-04-26
NO327153B1 (no) 2009-05-04
SI1425033T1 (sl) 2011-01-31
DE60238490D1 (de) 2011-01-13
UA82052C2 (uk) 2008-03-11
WO2003022303A2 (fr) 2003-03-20
CN1553810A (zh) 2004-12-08
HRP20040086A2 (en) 2004-12-31
ES2356895T3 (es) 2011-04-14
EA009279B1 (ru) 2007-12-28
AR036593A1 (es) 2004-09-22
DK1425033T3 (da) 2011-01-10
EA200400426A1 (ru) 2004-08-26
WO2003022303A3 (fr) 2003-12-18
CA2457851A1 (fr) 2003-03-20
US7402558B2 (en) 2008-07-22
HK1067865A1 (zh) 2005-04-22
EP1425033B1 (fr) 2010-12-01
MXPA04002257A (es) 2004-07-23

Similar Documents

Publication Publication Date Title
MEP39208A (en) USE OF hCG IN CONTROLLED OVARIAN HYPERSTIMULATION
BR0215405A (pt) Composições e processos de uso de collajolie
MEP38708A (en) Use of hcg and lh in controlled ovarian hyperstimulation
YU17003A (sh) Spiroheterociklični nitrili upotrebljivi kao reverzibilni inhibitori cisteinskih proteaza
CY2014038I2 (el) Αντι-il-6 αντισωματα, συνθεσεις, μεθοδοι και χρησεις
PA8565101A1 (es) Formas de dosificacion farmaceutica de liberacion controlada de un inhibidor de la proteina de transferencia de ester de colesterilo
IL156774A0 (en) Inhibitors of cruzipain and other cysteine proteases
DE60126838D1 (de) Amidoacetonitrile zur Bekämpfung von Endoparasiten
CY1108446T1 (el) Μη νευροτοξικοι παραγοντες ενεργοποιησης πλασμινογονου για την αντιμετωπιση αποπληξιας
ATE363531T1 (de) Claudin polypeptide
ATE356126T1 (de) 6,7-dihydro-5h-pyrazolo-1,2-aö pyrazol-1-one zur kontrolle von entzündungsfördernden cytokinen
DK1262236T3 (da) Fremgangsmåde til fremstilling af formet legeme af alfa-alumina
DK1383742T3 (da) Syntese og fremgangsmåder til anvendelse af tetrahydroindolonanaloge og derivater
DE60220973D1 (de) Material mit keiner Wärmeausdehnung und praktische Bauteile, die dieses Material verwenden
ATE292966T1 (de) Methode zur synthetisierung von leflunomid
ATE430600T1 (de) 2-(3,5-bis-trifluormethyl-phenyl)-n- 6-(1,1-dio o-1.lambda.6-thiomorpholin-4-yl)-4-(2-methyl- oder 4-fluor-2-methyl-substituiertes)phenyl-pyridin- - yl -n-methyl-isobutyramid
DK1274426T3 (da) Anvendelse af thioamidoxazolidinoner til behandling af knogleresorption og osteoporose
ATE277924T1 (de) Aryl-8-azabicyclo(3.2.1)octanes für die behandlung von depression
WO2002032884A3 (fr) Procedes de preparation de sulfonamides de biphenyl-isoxazole
BR0117078B1 (pt) mÉtodo para preparaÇço de couro utilizando protease e mÉtodo para tratamento de dejetos derivados do processamento do couro utilizando o mesmo.
SE0100374D0 (sv) Novel compositions of potassium channel openers and protein kinase c inhibitors and use thereof
WO2002057248A3 (fr) Inhibiteurs de la cruzipain et autres cysteine proteases
FI4950U1 (fi) Keraaminen tiili
ATA9412000A (de) Einrichtung, insbesondere brenner zur erzeugung von plasma
FR2832627B1 (fr) Composition cosmetique pour le traitement des poils, dont cheveux, et des follicules pileux